SC
FLXN

Selz Capital’s Flexion Therapeutics, Inc. FLXN Stock Holding History

Selz Capital’s Portfolio FLXN Stock Details FLXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		$7.04M Hold
340,000
– – 1.24% 32
2019
Q3 		$4.66M Sell
340,000
-90,000
-21% -$1.07M 1.17% 30
2019
Q2 		$5.29M Buy
430,000
+140,000
+48% +$1.62M 1.43% 23
2019
Q1 		$3.62M Buy
+290,000
New +$3.88M 0.69% 36

Other funds holding FLXN

MVP
Miller Value Partners Sarasota, Florida $423M AUM 49.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
KCM
Kingdon Capital Management New York $976M AUM 66.76% 1-Year Est. Return
TGHSA
TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Selz Capital's FLXN Position: Q4 2019 in Review

Selz Capital held its Flexion Therapeutics, Inc. (FLXN) position steady in Q4 2019 at 340,000 shares worth $7.04M. The position accounts for 1.24% of the portfolio, ranked #32.

Selz Capital first reported a position in FLXN in Q1 2019 and has held it in 4 quarters since. 133 funds tracked by Wall St. Rank hold FLXN as of Q4 2019.

  • Selz Capital held 340,000 shares of Flexion Therapeutics, Inc. worth $7.04M as of Q4 2019.
  • Selz Capital left its Flexion Therapeutics, Inc. share count unchanged in Q4 2019.
  • Flexion Therapeutics, Inc. made up 1.24% of Selz Capital's portfolio in Q4 2019, its #32 holding.
  • Selz Capital first reported a position in Flexion Therapeutics, Inc. in Q1 2019 and has held it in 4 quarters since.
  • 133 funds tracked by Wall St. Rank held Flexion Therapeutics, Inc. as of Q4 2019.

Based on Selz Capital's 13F filing for Q4 2019, filed 16 Jan 2020.